Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2905 posts found.

Lab testing

Lipidor to begin Phase III trial on psoriasis treatment

April 22, 2021
Phase III trials, lipidor, pharma, pharma news, psoriasis

Lipidor has submitted an application with the Indian Medical Products Agency to begin a Phase III trial on their drug …

News

Jubilant’s oral remdesivir formulation shows positive results in human trial

April 22, 2021
COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir

Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …

News
Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021
Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …

News

J&J COVID-19 vaccine to resume Europe rollout

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.

News

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021
Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …

News

Novartis multiple sclerosis treatment recommended by NICE

April 20, 2021
Manufacturing and Production NICE, Novartis, multiple sclerosis, pharma, pharma news

NICE have recommenced Novartis’ ofatumumab (Kesimpta) for the treatment of relapsing remitting MS (RRMS) in adult patients for use on …

News
Eli Lilly front sign

Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy

April 19, 2021
Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news

The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …

News

Sanofi multiple myeloma drug approved for second indication by EC

April 19, 2021
Sales and Marketing European Commission, Sanofi, Sarclisa, pharma, pharma news

The European Commission (EC) has approved a second indication of Sanofi’s Sarclisa drug for the treatment of adult patients with …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 16, 2021
Medical Communications covid 19 news, covid-19 news, news roundup, pharma, pharma news

A number of new COVID-19 developments have dominated the news again this week: J&J’s vaccine for the virus has been …

News

Merck cease development of $425 million COVID-19 treatment

April 16, 2021
Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news

Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.

News

EMA to begin review of GSK and Vir’s COVID-19 treatment

April 16, 2021
Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …

News
Gilead sign

Gilead’s bladder cancer drug gets FDA approval

April 15, 2021
FDA, Gilead, bladder cancer, bladder cancer treatment, pharma, pharma news

The FDA have granted accelerated approval to Gilead’s Trodelvy drug for the treatment of metastatic urothelial cancer (UC).

News
Roche building

Roche’s Evrysdi drug for SMA shown to significantly increase survival

April 15, 2021
PTC Therapeutics, Roche, pharma, pharma news, spinal muscular atrophy

Roche’s Evrysdi therapy for the treatment of children with type 1 spinal muscular atrophy (SMA) has been shown to increase …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 14, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen plenty of good and bad COVID-19 vaccine news; the EMA and CDC have launched investigations …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024